Defence Therapeutics (TSE:DTC) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Defence Therapeutics has appointed Dr. Maxime Parisotto as its new Chief Scientific Officer and Director of Science and Business Development, aiming to leverage his extensive experience in drug development and oncology to enhance shareholder value. The company also granted Dr. Parisotto 100,000 incentive stock options, highlighting its commitment to driving growth through strategic leadership.
For further insights into TSE:DTC stock, check out TipRanks’ Stock Analysis page.
